. In most of the above instances, the cholinergic response has been diminished or blocked by the specific muscarinic antagonist, atropine.
However, there has not been a direct binding study to demonstrate the presence of muscarinic cholinergic receptors associated with lymphocytes. The present investigation establishes that murine lymphocytes exhibit high-affinity binding for 3-quinuclidinyl benzilate (QNB), a specific, potent, and longlasting muscarinic agent which has been used previously to demonstrate and characterize cholinergic binding in neural tissue and smooth muscle (15, 16) . This muscarinic antagonist is a quasi-irreversible ligand, in that the dissociation of the QNB-receptor complex is slow (15 Proportions of thymus-derived (T) and bone-marrow-derived (B) lymphocytes were determined by immunofluorescence, with anti-Thy 1.2 and fluoresceinated rabbit anti-mouse immunoglobulin (18) . Phagocytic cells were detected by incubating the spleen cell suspension with latex beads and counting the cells that had ingested particles (19) .
Specific [3H]QNB binding
To assay specific binding of [3H]QNB, we incubated the ligand with 2 ml of Hanks' balanced salt solution (pH 7.2) containing 1.5 X 108 cells. Another tube contained, in addition to the above, 0.1 mM oxotremorine in order to determine nonspecific binding. All tubes were incubated for 60 min, after which the contents were filtered under reduced pressure through prewetted (phosphate buffer) glass fiber filters (GF/B) positioned over a sintered glass disc. The bowl of the filter makes an impression on the filter and thus outlines the filtering surface. To avoid clogging of the filters, four filters per tube were used. The 2-ml samples were applied in.0.5-ml portions per filter with a 1-ml syringe with a small needle. The 0.5-ml cell suspension was applied slowly (10 sec) under suction so as to form a lens-shaped droplet that did not spread over the entire area of the filter but was slowly pulled into (Fig. 1) , display a saturation curve. This curve was constructed from three di-fferent cell preparations prepared on different occasions. This saturation curve indicates that a limited number of specific binding sites are involved. That the limit is approached at low concentrations of QNB meets the requirements for a highaffinity muscarinic receptor. The dissociation constant is on the order of 1 X 10-9 M and is comparable to the value reported for erythrocytes (10) but an order of magnitude higher than that for neural tissue (15) . As a further test, it was shown that atropine, a specific muscarinic antagonist, 10-6 M and 10-4 M blocked the specific binding of QNB ( Table 1 ). The differences in the radioactive counts with and without atropine were about the same as obtained with oxotremorine but slightly higher. The specific-binding with 1 The method used here for determining muscarinic receptors was essentially the same as that of Yamamura and Snyder (15) except that the present study used whole cells whereas previous work used sonicated tissue. After the ammonium chloride procedure, the erythrocyte cell contribution to the total leukocyte cell suspension was less than 0.1%, as determined with a hemocytometer. The cellular distribution was: T lymphocytes, 20 i 3% (SEM); B lymphocytes, 64 4 3% (SEM); phagocytes, 8 i: 2% (SEM); and "null cells" (cells unidentified as T, B, or phagocytic), 8%.
The lymphocyte-binding data are averages over different types of leukocytes. Therefore, adherent cells, predominantly macrophages, were removed and their binding properties determined. The adherent cells showed specific binding corresponding to about 400 muscarinic receptors per cell at 1.34 nM QNB. Although the number of macrophage-binding sites is higher than that for lymphocytes, the number of macrophages is so small that the saturation value assigned to lymphoctyes is not appreciably changed.
Binding by T lymphocytes has not been distinguished from binding by B lymphocytes, and it is possible that there is a wide difference in the binding capabilities. (20) . The value for muscarinic binding sites in lymphocytes is comparable to the estimate for insulin-binding sites in transformed lymphocytes and rat peritoneal macrophages (21) .
